| Document |
Document Title |
|
WO/2003/053915A2 |
This invention relates to compounds of the Formula (I):(Chemical formula should be inserted here as it appears on abstract in paper form)(I)or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the tre...
|
|
WO/2003/053905A1 |
A process for the production of 1R pyrethroid esters of formula (IIIA) or (IIIB), wherein A and B are independently chlorine or bromine or one of A or B is chlorine and the other is trifluoromethyl and R is a pyrethroid alcohol fragment,...
|
|
WO/2003/045962A1 |
The present invention relates to a novol class of supermolecules carboplatinum derivatives represented by general formula (I), wherein B is a polycarboxylic represented by general formula (II), wherein (R1) and (R2) and (n) is defined as...
|
|
WO/2003/040230A1 |
Compounds and compositions comprising specific metal salts of bicyclo[2.2.1]heptane dicarboxylate salts in order to provide highly desirable properties within polyolefin articles are provided. The inventive salts and derivatives thereof ...
|
|
WO/2003/006413A1 |
Novel norbornene derivatives bearing fluorinated ketone or fluorinated alcohol moieties attached directly to norbornene skeleton, which are useful as material of chemically amplified photoresists for F2 laser lithography having excellent...
|
|
WO/2002/098967A1 |
Compounds of and compositions comprising specific salts of saturated [2.2.2] dicarboxylate in order to provide highly desirable properties within thermoplastic (e.g., polyolefin) articles are provided. The inventive salts and derivatives...
|
|
WO/2002/094759A1 |
Bicyclic nucleator compounds that provide highly versatile nucleation benefits for different polyolefins are provided. Such nucleator compounds provide very high peak crystallization temperatures and significantly reduced crystallization...
|
|
WO/2002/085839A1 |
The compounds of the instant invention are bicyclic or tricyclic amino acids useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis...
|
|
WO/2002/079134A1 |
The present invention relates to a process for the manufacture of compounds of general formula (I), wherein R?2a¿, R?2b¿ are, independently from each other, hydrogen; halogen; lower alkoxy; cyano; -COOH; lower alkoxycarbonyl; or lower ...
|
|
WO/2002/077092A1 |
Compounds and compositions comprising specific metal salts of bicyclo[2.2.1]heptane dicarboxylate salts in order to provide highly desirable properties within polyolefin articles are provided. The inventive salts and derivatives thereof ...
|
|
WO/2002/066412A1 |
The invention relates to a method for producing cyclohexane dicarboxylic acids or derivatives thereof, e.g esters and anhydrides, wherein diene maleic acid anhydride mixtures, especially mixtures of butadiene maleic acid anhydrides or mi...
|
|
WO/2002/057201A2 |
Higher diamondoid derivatives capable of taking part in polymerization reactions are disclosed as are intermediates to these derivatives, polymers formed from these derivatives and methods for preparing the polymers.
|
|
WO/2002/050013A1 |
A carboxylic acid compound having cyclopropane ring(s) of the formula (I): wherein R is alkyl or alkenyl optionally having one or more 1,2-cyclopropylene in a carbon chain and/or optionally having cyclopropyl at the end of a chain,X is a...
|
|
WO2001056959B1 |
A substance including the chemical structures of bicyclo[3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes m...
|
|
WO/2002/006202A1 |
A process for producing compounds of formula (VIIa) and (VIIb) wherein X is a leaving group; Y and Y?1¿ are idependently Cl or Br; and Z is Cl, Br or a haloalkyl group which process comprises a) reacting a compound of formula (VII) wher...
|
|
WO/2001/096273A1 |
A process is provided, by which 1-substituted-cyclo-hexanecarbonyl halides of the general formula [1] can be prepared industrially practically at an extremely low cost: [1] wherein R is linear or branched C¿1-10? alkyl, C¿3-10? cycloal...
|
|
WO/2001/092200A1 |
The invention relates to a novel process for the preparation of certain cyclopropyl carboxylic acid esters and other cyclopropyl carboxylic acid derivatives; a novel process for the preparation of dimethylsulfoxonium methylide and dimeth...
|
|
WO/2001/064696A1 |
The present invention relates to dicarboxylato diammine platinum derivatives of formula (I), wherein R?1¿ and R?2¿ are defined as in the description, to method for preparing them, and to antitumor chemical compositions comprising them....
|
|
WO/2001/051455A1 |
Cyanohydrin homologation of the 4-cyanocyclohexanone (D) provides a 4-cyanocyclohexanoic acid (I).
|
|
WO/2001/034592A1 |
The invention relates to 5-halo-4-fluoro-4,7,7-trimethyl-3-oxabicyclo[4.1.0]heptane-2
-ones, to a method for their production and to their use in the production of cyclopropane carboxylic acids. The invention relates to the compounds of ...
|
|
WO/2001/010822A1 |
This invention relates to a method for preparing certain acids of formula (I) via a chloroepoxy ester, which are useful as phosphodiesterase 4 inhibitors.
|
|
WO/2001/009076A2 |
This invention relates to new RAR selective retinoid agonists of formula (I) wherein the symbols are as defined in the specification to their pharmaceutically acceptable salts, individual isomers or to a racemic or non-racemic mixture; t...
|
|
WO/2000/078853A1 |
The invention relates to the use of a cyclohexane polycarboxylic acid or of one of its derivatives, or of a mixture of one or more of said acids as plasticizers in the production of plastics which are rated toxicologically favourable. In...
|
|
WO/2000/078701A1 |
The present invention relates to an improved process for the hydrogenation of phthalic acids over a supported palladium catalyst. Phthalic acids are hydrogenated with improved selectivity in aqueous solution over palladium on carbon cata...
|
|
WO/2000/076991A1 |
A process is provided for preparing chiral cyclopropane carboxylic acids, preferably of structure (I) which are intermediates used in preparing acyl guanidine sodium/proton exchange (NHE) inhibitors.
|
|
WO/2000/073253A1 |
Compounds are disclosed that have the chemical structure of Formula (II) and (IIB) and their produg esters and acid-addition salts, and that are useful as Interleukin-1 and Tumor Necrosis Factor-a modulators, and thus are useful in the t...
|
|
WO/2000/046174A1 |
Disclosed herein is a method of preparing cyclohexanecarboxylic acid in which 1,3-butadiene and acrylic acid are subjected to [2+4] Diels-Alder reaction to produce 3-cyclohexene-1-carboxylic acid which is then hydrogenated. The [2+4] Die...
|
|
WO/2000/046175A1 |
The present invention relates to a new microbial process for the preparation of compound formula (I) from a compound of general formula (II) wherein R stands for an alkali metal or ammonium ion, by the submerged cultivation of a mold str...
|
|
WO/2000/014080A1 |
4-Methyl-4-(4-methylpent-3-en-1-yl)-2-oxetanone of formula (I) or its oligomer are new intermediate products for the preparation of a series of geranic acid derivatives. Geranic acid derivatives are important synthetic building blocks in...
|
|
WO/1999/062913A1 |
Rare earth carboxylates in solid form are prepared or treated with a solubilizing agent to improve the solids solubility in aliphatic solvents. Other methods, such as treatment of the aliphatic solvent, to improve the solubility of solid...
|
|
WO/1999/062875A1 |
The present invention relates to novel amidino compounds of formula (I), or a salt, solvate, or physiologically functional derivative thereof; wherein R?1¿ is selected from C¿1-4? alkyl, C¿3-4? cycloalkyl, C¿1-4? hydroxyalkyl, and CÂ...
|
|
WO/1999/054324A1 |
A process for the preparation of $i(cis)-6,6-dimethyl-3-oxa-bicyclo[3.1.0]hexan-2-one which comprises either: 1) reacting a sulphonic ester of $g(b),$g(b)-dimethyl-$g(g)-(hydroxymethyl)-$g(g)-butyrolacto
ne with a compound of formula M(C...
|
|
WO/1999/052877A1 |
Non-antibody multimeric receptor ligands, methods for making and identifying them and their use for agonizing or antagonizing multimeric receptors.
|
|
WO/1999/052849A1 |
The present invention relates to the oxidation of a primary alcohol of Formula (II) to the carboxylic acid of Formula (I): R?1¿CH¿2?OH$m(7)R?1¿CO¿2?H.
|
|
WO/1999/051562A1 |
The present invention provides new retinoid compounds and uses of the compounds in humans and animals for chemoprevention of skin and/or breast cancer and for therapy of leukemia.
|
|
WO/1999/047489A1 |
The invention relates to a process for the manufacture of (2S,2'R,3'R)-2-(2,3-dicarboxyl-cyclopropyl)-glycine of formula (I), wherein R¿2? is hydrogen or tritium. The compounds can be used as a pharmacological tool to study the function...
|
|
WO/1999/032426A1 |
Compounds of formula (I) in which R represents the remainder of an alcohol used in the pyrethroid series, in all their possible stereoisomer forms as well as their mixtures, and compositions comprising them. The compounds of formula (I) ...
|
|
WO/1999/032427A1 |
The invention relates to a method for hydrogenating a benzene polycarboxylic acid or a derivative thereof or of a mixture comprised of two or more thereof with a gas containing hydrogen in the presence of a catalyst. Said catalyst compri...
|
|
WO/1999/023056A1 |
The present invention relates to a high-efficiency anti-epileptic preparation that comprises one of several new derivatives of alicyclic carboxylic acid. In a same aspect, this invention also relates to the alkaline metal salts or alkali...
|
|
WO/1999/021824A1 |
The invention is a novel series of cyclic amino acids which are useful in the treatment of epilepsy, faintness attacks, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, gastrointestinal disorder...
|
|
WO/1999/012883A1 |
The invention relates to a method for producing cyclopentanone and cyclopentene-1-carboxylic acid or their esters of formula (I) COOR, wherein R represents hydrogen or an aliphatic radical with 1 to 6 C-atoms or a cycloaliphatic, araliph...
|
|
WO/1998/030329A1 |
At least one functional group selected between nitro and carboxyl groups can be introduced into a substrate by bringing the substrate into contact with at least one reactant selected from among (i) nitrogen oxides and (ii) carbon monoxid...
|
|
WO/1998/025875A1 |
Compounds of the formula (1) where the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist and/or retinoid inverse-agonist-like biological activity.
|
|
WO/1998/023575A1 |
The present invention relates to asiatic acid derivatives having a modified A-ring, which are represented by formula (1), and anticancer agents and liver-function protecting agents containing the same as an active component.
|
|
WO/1998/018745A1 |
A process for the removal of catalyst poisons from hops and hop extracts is disclosed. After processing the hops to extract the alpha or beta acids therein, the alpha or beta acids are treated with activated nickel catalyst. The activate...
|
|
WO/1998/010091A1 |
A process for preparing a particular optically active isomer of a 2-halo-2-fluorocyclopropanecarboxylic acid from a 2-halo-2-fluorocyclopropanecarboxylic ester comprising a mixture of optically active isomers. The process is characterize...
|
|
WO/1997/047194A1 |
Compounds represented by formula (I), and pharmaceutically acceptacle salts thereof; and their method of preparation are provided. Compounds of the above formula are influenza virus neuraminidase inhibitors and can be used in treating pa...
|
|
WO/1997/042156A1 |
The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
|
|
WO/1997/042155A1 |
The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
|
|
WO/1997/003941A1 |
The compounds 3-(2,2-dichloro-3,3,3-trifluoro-1-hydroxypropyl)-2,2-dimethy
l-(1R,3R)-cyclopropane carboxylic acid, cis-3-(2,2-dichloro-3,3,3-trifluoro-1-hydroxypropyl)-2,2-dim
ethyl-cyclopropane carboxylic acid and (1R,5S)-4-(1,1-dichlor...
|
